{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:47:05Z","timestamp":1697892425504},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00431715","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T03:47:24Z","timestamp":1100144844000},"page":"228-232","source":"Crossref","is-referenced-by-count":8,"title":["Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats"],"prefix":"10.1007","volume":"86","author":[{"given":"K.","family":"Murugaiah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Theodorou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Clow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. D.","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archpsyc.1973.01750340009001","volume":"28","author":"American College of Neuropsychopharmacology, Food and Drug Administration Task Force","year":"1973","unstructured":"American College of Neuropsychopharmacology, Food and Drug Administration Task Force (1973). Neurological syndromes associated with antipsychotic drug use. Arch Gen Psychiatr 28:463?467","journal-title":"Arch Gen Psychiatr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000468353","volume":"14","author":"J Ananth","year":"1979","unstructured":"Ananth J (1979) Drug-induced dyskinesia. Int Pharmacopsychiatr 14:21?33","journal-title":"Int Pharmacopsychiatr"},{"key":"CR3","first-page":"993","volume-title":"Psychopharmacology: A generation of progress","author":"RJ Baldessarini","year":"1978","unstructured":"Baldessarini RJ, Tarsy D (1978) Tardive dyskinesia. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress, Raven Press, New York, pp 993?1004"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00427654","volume":"69","author":"J Bannet","year":"1980","unstructured":"Bannet J, Belmaker RH, Ebstein RP (1980) The effects of drug holidays in an animal model of tardive dyskinesia. Psychopharmacology 69:223?224","journal-title":"Psychopharmacology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00426727","volume":"61","author":"MB Bowers Jr","year":"1929","unstructured":"Bowers MB Jr, Moore D, Tarsy D (1929) Tardive dyskinesia: A clinical test of the supersensitivity hypothesis. Psychopharmacology 61:137?141","journal-title":"Psychopharmacology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/278059a0","volume":"278","author":"A Clow","year":"1979","unstructured":"Clow A, Jenner P, Theodorou A, Marsden CD (1979a) Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months. Nature 278:59?61","journal-title":"Nature"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-2999(79)90499-0","volume":"57","author":"A Clow","year":"1979","unstructured":"Clow A, Jenner P, Marsden CD (1979b) Changes in dopamine-mediated behaviour during one-years neuroleptic administration. Eur J Pharmacol 57:365?375","journal-title":"Eur J Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00433087","volume":"69","author":"A Clow","year":"1980","unstructured":"Clow A, Theodorou A, Jenner P, Marsden CD (1980a) A comparison of striatal and mesolimbic dopamine function in the rat during 6 month trifluoperazine administration. Psychopharmacology 69:227?233","journal-title":"Psychopharmacology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(80)90437-9","volume":"63","author":"A Clow","year":"1980","unstructured":"Clow A, Theodorou A, Jenner P, Marsden CD (1980b) Changes in rat striatal dopamine turnover and receptor activity during one years' neuroleptic administration. Eur J Pharmacol 63:135?144","journal-title":"Eur J Pharmacol"},{"key":"CR10","first-page":"336","volume":"2","author":"TJ Crow","year":"1982","unstructured":"Crow TJ, Cross AJ, Johnstone EC, Owen F, Owens DGC, Waddington JL (1982) Abnormal involuntary movements in schizophrenia: Are they related to the disease process or its treatment? Are they consistent with changes in dopamine receptors? J Clin Psychopharmacol 2:336?340","journal-title":"J Clin Psychopharmacol"},{"key":"CR11","unstructured":"Degkwitz R (1969) Extrapyramidal motor disorders following long-term treatment with neuroleptic drugs. In: Crane GE, Gardiner R Jr (eds) Psychotropic drugs and dysfunction of basal ganglia. US Public Health Service Publication No. 1938, Washington D.C., pp 22?32"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.1979.01780050095012","volume":"36","author":"DV Jeste","year":"1979","unstructured":"Jeste DV, Potkin SG, Sinha S, Feder S, Wyatt RJ (1979) Tardive dyskinesia ? reversible and persistent. Arch Gen Psychiatr 36:585?590","journal-title":"Arch Gen Psychiatr"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","volume":"39","author":"JM Kane","year":"1982","unstructured":"Kane JM, Smith JM (1982) Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatr 39:473?481","journal-title":"Arch Gen Psychiatr"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.130.1.82","volume":"130","author":"HL Klawans","year":"1973","unstructured":"Klawans HL (1973) The pharmacology of tardive dyskinesia. Am J Psychiatr 130:82?86","journal-title":"Am J Psychiatr"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-2952(78)90233-2","volume":"27","author":"JE Leysen","year":"1978","unstructured":"Leysen JE, Gommeren W, Laduron PM (1978) Spiperone, a ligand of choice for neuroleptic receptors, I. kinetics and characteristics of in vitro binding. Biochem Pharmacol 27:307?316","journal-title":"Biochem Pharmacol"},{"key":"CR16","first-page":"219","volume-title":"Psychotic Aspects of Neurologic disease","author":"CD Marsden","year":"1975","unstructured":"Marsden CD, Tarsy D, Baldessarini RJ (1975) Spontaneous and drug-induced movement disorders in psychotic patients. In: Benson DF, Blumer D (eds) Psychotic Aspects of Neurologic disease. Grune and Stratton, New York, pp 219?266"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S003329170003960X","volume":"10","author":"CD Marsden","year":"1980","unstructured":"Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side-effects of drugs. Psychol Med 10:55?72","journal-title":"Psychol Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0306-4522(83)90218-X","volume":"10","author":"K Murugaiah","year":"1983","unstructured":"Murugaiah K, Theodorou A, Jenner P, Marsden CD (1983) Alteration in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months. Neuroscience 10:811?819","journal-title":"Neuroscience"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00431457","volume":"84","author":"NMJ Rupniak","year":"1984","unstructured":"Rupniak NMJ, Kilpatrick G, Hall MD, Jenner P, Marsden CD (1984) Differential alterations in striatal dopamine receptor supersensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Psychopharmacology 84:503?511","journal-title":"Psychopharmacology"},{"key":"CR20","first-page":"431","volume":"12","author":"D Tarsy","year":"1977","unstructured":"Tarsy D, Baldessarini RJ (1977) The pathophysiologic basis of tardive dyskinesia. Biol Psychiatr 12:431?450","journal-title":"Biol Psychiatr"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00431715\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T22:39:42Z","timestamp":1554849582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00431715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00431715"],"URL":"https:\/\/doi.org\/10.1007\/bf00431715","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}